FULGENT GENETICS, INC. Finance Lease, Principal Payments
FULGENT GENETICS, INC. (FLGT) reported Finance Lease, Principal Payments of $176.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-07-30
- FULGENT GENETICS, INC. finance lease, principal payments for the quarter ending 2026-06-30 was $88.00K, a 1.15% increase year-over-year.
- FULGENT GENETICS, INC. finance lease, principal payments for the quarter ending 2026-03-31 was $88.00K, a 35.29% decline year-over-year.
- FULGENT GENETICS, INC. finance lease, principal payments for the quarter ending 2025-12-31 was $88.00K, a 35.29% decline year-over-year.
- FULGENT GENETICS, INC. finance lease, principal payments for the quarter ending 2025-09-30 was $88.00K, a 34.81% decline year-over-year.
- FULGENT GENETICS, INC. finance lease, principal payments for fiscal 2025 was $399.00K, a 26.65% decline from fiscal 2024.
- FULGENT GENETICS, INC. finance lease, principal payments for fiscal 2024 was $544.00K, a 25.48% decline from fiscal 2023.
- FULGENT GENETICS, INC. finance lease, principal payments for fiscal 2023 was $730.00K, a 4.29% increase from fiscal 2022.
- FULGENT GENETICS, INC. finance lease, principal payments for fiscal 2022 was $700.00K, a 9900.00% increase from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $176.00K 10-Q · filed 2026-07-30 | $264.00K derived: sum of 3 quarters · filed 2026-07-30 | $352.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $88.00K 10-Q · filed 2026-05-01 | $176.00K derived: sum of 2 quarters · filed 2026-05-01 | $264.00K derived: sum of 3 quarters · filed 2026-05-01 | $351.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $176.00K derived: sum of 2 quarters · filed 2026-02-27 | $263.00K derived: sum of 3 quarters · filed 2026-07-30 | $399.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $175.00K derived: sum of 2 quarters · filed 2026-07-30 | $311.00K 10-Q · filed 2025-11-07 | $447.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $223.00K 10-Q · filed 2026-07-30 | $359.00K derived: sum of 3 quarters · filed 2026-07-30 | $494.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $136.00K 10-Q · filed 2026-05-01 | $272.00K derived: sum of 2 quarters · filed 2026-05-01 | $407.00K derived: sum of 3 quarters · filed 2026-05-01 | $545.00K derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $271.00K derived: sum of 2 quarters · filed 2026-02-27 | $409.00K derived: sum of 3 quarters · filed 2026-02-27 | $544.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $273.00K derived: sum of 2 quarters · filed 2025-11-07 | $408.00K 10-Q · filed 2025-11-07 | $546.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $273.00K 10-Q · filed 2025-08-01 | $411.00K derived: sum of 3 quarters · filed 2026-02-27 | $540.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $135.00K 10-Q · filed 2025-05-02 | $273.00K derived: sum of 2 quarters · filed 2026-02-27 | $402.00K derived: sum of 3 quarters · filed 2026-02-27 | $633.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $267.00K derived: sum of 2 quarters · filed 2026-02-27 | $498.00K derived: sum of 3 quarters · filed 2026-02-27 | $730.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $360.00K derived: sum of 2 quarters · filed 2024-11-08 | $592.00K 10-Q · filed 2024-11-08 | $823.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $463.00K 10-Q · filed 2024-08-02 | $694.00K derived: sum of 3 quarters · filed 2025-02-28 | $933.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $232.00K 10-Q · filed 2024-05-03 | $463.00K derived: sum of 2 quarters · filed 2025-02-28 | $702.00K derived: sum of 3 quarters · filed 2025-02-28 | $851.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $470.00K derived: sum of 2 quarters · filed 2025-02-28 | $619.00K derived: sum of 3 quarters · filed 2025-02-28 | $700.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $239.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $388.00K derived: sum of 2 quarters · filed 2023-11-03 | $469.00K 10-Q · filed 2023-11-03 | $473.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $149.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $230.00K 10-Q · filed 2023-08-04 | $234.00K derived: sum of 3 quarters · filed 2024-02-28 | |
| 2022-03-31 | $81.00K 10-Q · filed 2023-05-05 | $85.00K derived: sum of 2 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.00K 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $3.00K 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |